Yifei Pharmaceutical's semi -annual net profit of 3.9896 million yuan increased by 569.20% year -on -year

On August 10, Yifei Pharmaceutical (code: 872460.NQ) released the performance report of the 2022 Half -Annual Report.

From January 1, 2022-June 30, 2022, the company realized operating income of 53.63 million yuan, an increase of 109.46%year-on-year, and net profit was 39.896 million yuan, an increase of 569.20%year-on-year, and the basic earnings per share were 0.1600 yuan.

The company's industry is chemical products.

During the company's reporting period, the total assets at the end of the period were 98.8373 million yuan, the operating profit was 4.1636 million yuan, the accounts receivable were 8.64 million yuan, and the net cash flow generated by operating activities was 6.747 million yuan.The cash was 52.5265 million yuan.

Yifei Pharmaceutical, the company's full known as Shandong Yifei Pharmaceutical Co., Ltd., was established on May 04, 2010. Zhu Chuanwu, the current general manager, is the technical research and transfer, production and sales of fine chemicals and biochemicals;Production and sales of feed additives.Sales chemical raw materials and products; import and export of goods and technology.

- END -